Key Opinion Leaders, Drugs for Smoking Cessation, and Transparen...

Courtesy Health Care Renewal  Wed, 07/02/2008 - 15:49

A perspectives article from the April 1 issue of the Annals of Internal Medicine has provoked a slowly growing controversy.

(1) Let me summarize the main points of the article before getting to the controversy.

As the title, "the case for treating tobacco dependence as a chronic disease," suggests, the authors argue "for some smokers, long-term pharmacotherapy [which] is the difference between tobacco abstinence and lifelong smoking," based on the argument that smoking is like a chronic disease. ...

Sponsors

 

Related items

BLOGSCAN - Disease Mongering and Indefinite Use of Smoking...
On the Bioethics Forum, Dr Adriane Fugh-Berman and Dr Douglas Melnick discuss what appears to be the latest example of disease-mongering. An article...

Embargoed clinical news from Annals of Internal Medicine
(American College of Physicians) This release contains information about three studies being published in the Sept. 2, 2008, issue of Annals of...

Merck scientific debate hits bottom, keeps on digging?
I find Merck Scientific Affairs executive Jonathan Edelman's op ed in today's Philadelphia Inquirer on the Vioxx "ADVANTAGE seeding trial"...

ADVANTAGE: Who was actually in charge of R&D? And other...
Roy Poses addresses many of the controversial issues raised by the Annals of Internal Medicine article "The ADVANTAGE seeding trial: a review of...

Bad Seed: the ADVANTAGE Trial of Vioxx
An article in the Annals of Internal Medicine by Hill et al(1), and the accompanying editorial by Sox and Rennie(2) have created quite a stir in the...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com